Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

被引:22
|
作者
Vena, Gino A. [1 ]
Cassano, Nicoletta [1 ]
Coco, Valeria [2 ]
De Simone, Clara [2 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Unit Dermatol & Venereol, I-70124 Bari, Italy
[2] Univ Cattolica Sacro Cuore, Unit Dermatol, I-00168 Rome, Italy
关键词
Antihypertensive drugs; cutaneous adverse drug reactions; drug-induced dermatitis; eczema; hydrochlorothiazide; CAPTOPRIL; DRUG; SURVEILLANCE; BRADYKININ; IRBESARTAN; ERUPTION;
D O I
10.3109/08923973.2013.797992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cutaneous adverse drug reactions (ADRs) to antihypertensive drugs have been frequently reported. We describe a peculiar clinical pattern of cutaneous ADR, represented by an eczematous reaction induced by certain antihypertensive drugs that we observed in elderly patients. The case series consisted of 23 hypertensive patients aged 66-87 years; 19 of them were taking another drug in addition to the suspected antihypertensive medication and 15 were on polytherapy with three or more drugs to treat multiple comorbidities. The antihypertensive culprit agents were angiotensin-converting enzyme (ACE) inhibitors in 9 patients, ACE-inhibitors combined to hydrochlorothiazide (HCT) in 7 subjects, angiotensin II receptor blockers alone in 2 patients and associated with HCT in 5 cases. The cutaneous ADR was characterized by an eczematous rash that was generalized in 16 patients and localized in 7 cases, with predominant involvement of lower limbs. Such lesions developed after a latency of 4-30 months and were associated with moderate-to-severe itch, usually unresponsive to oral antihistamines. Histopathological diagnosis was available for 9 cases, confirming the presence of a spongiotic dermatitis with possible associated psoriasiform skin changes.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [41] The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus
    Strauss, Martin H.
    Hall, Alistair S.
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (02) : 124 - 129
  • [42] Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review
    Palleria, Caterina
    Bennardo, Luigi
    Dastoli, Stefano
    Iannone, Luigi F.
    Silvestri, Martina
    Manti, Antonia
    Nistico, Steven P.
    Russo, Emilio
    De Sarro, Giovambattista
    DERMATOLOGIC THERAPY, 2019, 32 (01)
  • [43] Angiotensin-Converting Enzyme Inhibitors Induce Cough
    Yilmaz, Insu
    TURKISH THORACIC JOURNAL, 2019, 20 (01): : 36 - 42
  • [44] Angiotensin-converting enzyme inhibitors in antihypertensive therapy
    Luft F.C.
    Current Hypertension Reports, 2000, 2 (2) : 165 - 166
  • [45] The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis
    Pongpanich, Punnaka
    Pitakpaiboonkul, Pasvich
    Takkavatakarn, Kullaya
    Praditpornsilpa, Kearkiat
    Eiam-Ong, Somchai
    Susantitaphong, Paweena
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (12) : 2261 - 2278
  • [46] Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
    Raimondi, Sara
    Botteri, Edoardo
    Munzone, Elisabetta
    Cipolla, Carlo
    Rotmensz, Nicole
    DeCensi, Andrea
    Gandini, Sara
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 212 - 219
  • [47] Angioedema induced by angiotensin-converting enzyme inhibitors
    Campo, Paloma
    Fernandez, Tahia D.
    Canto, Gabriela
    Mayorga, Cristobalina
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 13 (04) : 337 - 344
  • [48] PLATELET ANGIOTENSIN-II IN CEREBROVASCULAR ACCIDENT AND THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    HAYAKAWA, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1992, 20 (03) : 289 - 294
  • [49] Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier, Roxana
    Faure, Sebastien
    Mazouz, Hakim
    Boutitie, Florent
    Serot, Jean-Marie
    Achard, Jean-Michel
    Godefroy, Olivier
    Hanon, Olivier
    Temmar, Mohammed
    Albu, Adriana
    Strandgaard, Svend
    Wang, Jiguang
    Black, Sandra E.
    Fournier, Albert
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (09) : 1289 - 1305
  • [50] NON-ANGIOTENSIN EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    SUNMAN, W
    SEVER, PS
    CLINICAL SCIENCE, 1993, 85 (06) : 661 - 670